This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout



Data availability
The EPIC web portal and its associated database and analytic tools will be made available for investigation as described in the manuscript to researchers who do not belong to a for-profit entity.
Code availability
The web applications Sci-Atlas Miner and Discovery Tool can be freely accessed on all modern web browsers at https://www.epicimmuneatlas.org. The source code of the R Shiny applications and R scripts for the creation of Immune Atlas data files are available on request for academic use.
Change history
28 May 2020
A Correction to this paper has been published: https://doi.org/10.1038/s41587-020-0574-4
References
Gibbons, D. et al. Nat. Med. 20, 1206–1210 (2014).
van den Broek, T., Borghans, J. A. M. & van Wijk, F. Nat. Rev. Immunol. 18, 363–373 (2018).
Reen, D. J. Vaccine 16, 1401–1408 (1998).
Beck, R. & Lam-Po-Tang, P. R. Immunol. Cell Biol. 72, 440–444 (1994).
van der Maaten, L. & Hinton, G. J. Mach. Learn. Res. 9, 2579–2605 (2008).
Blanco, E. et al. J. Allergy Clin. Immunol. 141, 2208–2219.e16 (2018).
Van Gassen, S. et al. Cytometry A 87, 636–645 (2015).
Ritchie, M. E. et al. Nucleic Acids Res. 43, e47 (2015).
Johnson, W. E., Li, C. & Rabinovic, A. Biostatistics 8, 118–127 (2007).
Bhattacharya, S. et al. Immunol. Res. 58, 234–239 (2014).
Zalocusky, K. A. et al. Cell Rep. 25, 513–522.e3 (2018).
Hu, Z. et al. Cell Rep. 24, 1377–1388 (2018).
Acknowledgements
This research is supported by the National Research Foundation Singapore under its NMRC Centre Grant Programme (NMRC/CG/M003/2017) and administered by the Singapore Ministry of Health’s National Medical Research Council. Other grant support from NMRC (NMRC/TA/0059/2017, NMRC/STaR/020/2013, NMRC/MOHIAFCAT2/2/08, MOHIAFCAT2/0001/2014, NMRC MOHIAFCAT1-6003, TCR15Jun006, NMRC/CIRG/ 1460/2016, MH 095:003\016-0002), Duke-NUS, A*STAR-BMRC (IAF311020) and BMRC (SPF2014/005) is gratefully acknowledged. The pediatric patients were recruited with the strong support of Yew Nam Siow and the Department of Anaesthesia, KK Women’s and Children’s Hospital. Testing of EPIC and feedback by Antonio La Cava, Femke van Wijk, Eveline Delemarre, Antonio Bertoletti, Michelle Hong Li Wen, Matthew Kirkey and Rosa Bacchetta are greatly appreciated. We also acknowledge Loshinidevi Thana Bathi for processing the large number of samples used in EPIC.
Author information
Authors and Affiliations
Contributions
S.A. conceived and oversaw the study. E.S.C.L., K.T.Y., A.Y.J.T., S.Y.L., A.L., T.A., M.S.Z.N., T.P.N., S.C., M.G., A.M., S.P.T., S.K.N. and C.F.Y. oversaw the ethics approval, patients screening and recruitment. J.G.Y., S.L.P., F.A., L.L., A.J.M.L. and K.N.Y. performed the experiments. S.L.P. oversaw and coordinated all the mass cytometry staining. P.L. and J.G.Y. performed the initial bioinformatics analysis with input from J.C., F.G., C.-A.D., B.S.P. and J.L. M.W. developed the R-Shiny-based Sci-Atlas Miner tool and P.K. developed the Discovery tool. P.K. and C.J.H.C. constructed the web-based interface and server system. S.A., J.G.Y., M.W. and P.K. wrote the manuscript with input from all other authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary information
Supplementary Methods
Rights and permissions
About this article
Cite this article
Yeo, J.G., Wasser, M., Kumar, P. et al. The Extended Polydimensional Immunome Characterization (EPIC) web-based reference and discovery tool for cytometry data. Nat Biotechnol 38, 679–684 (2020). https://doi.org/10.1038/s41587-020-0532-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0532-1
This article is cited by
-
How does age determine the development of human immune-mediated arthritis?
Nature Reviews Rheumatology (2022)
-
Juvenile idiopathic arthritis
Nature Reviews Disease Primers (2022)
-
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
Nature Communications (2022)
-
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
Nature Communications (2022)
-
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Nature Communications (2021)